China Pharma (NYSE:CPHI) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of China Pharma (NYSE:CPHI) in a report released on Friday. The brokerage issued a hold rating on the stock.

China Pharma Stock Performance

NYSE:CPHI opened at $0.20 on Friday. China Pharma has a 1 year low of $0.17 and a 1 year high of $1.16. The stock’s fifty day moving average price is $0.23 and its two-hundred day moving average price is $0.24. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.26 and a current ratio of 0.79.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.